A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
Conditions
- High-grade Glioma
- Lung Cancer
- Head & Neck Cancer
- Sarcoma
- Melanoma
Interventions
- DRUG: Fluciclatide Injection - (AH111585 (F18))
Sponsor
GE Healthcare